Who is sponsoring NCT03579901?

NCT03579901 is sponsored by Motiva USA LLC.

What condition does NCT03579901 study?

NCT03579901 studies Breast Implants.

Is NCT03579901 still recruiting?

NCT03579901 is currently active, enrolled. Last updated 12 November 2025.

Last reviewed 2025-11-12 · How we verify

NCT03579901

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of the Safety and Effectiveness of Motiva Implants®

Active, enrolled NA Last updated 12 November 2025

What this trial tests

NA trial testing Silicone gel-filled breast implants - Motiva Implants® Investigational breast implants in Breast Implants in 800 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

6 April 2018

Primary endpoint
30 August 2032

28 February 2033

Quick facts

Lead sponsor	Motiva USA LLC
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	other
Enrollment	800
Start date	6 April 2018
Primary completion	30 August 2032
Estimated completion	28 February 2033
Sites	29 locations across Sweden, United States, Germany

Drugs / interventions tested

Silicone gel-filled breast implants - Motiva Implants® Investigational breast implants

Conditions studied

Breast Implants — all drugs for Breast Implants →

Sponsor

Motiva USA LLC — full company profile →

Who can join

Adults 18 to 70, female only, with Breast Implants. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the safety and effectiveness Motiva Implants® in women who are undergoing primary breast augmentation, primary breast reconstruction or revision breast surgery.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Hydrogels in the clinic: An update.
Clegg JR, Adebowale K, Zhao Z, Mitragotri S. · · 2024 · cited 64× · PMID 39545079 · DOI 10.1002/btm2.10680
The Study of the Safety and Effectiveness of Motiva SmoothSilk Silicone Gel-Filled Breast Implants in Patients Undergoing Primary and Revisional Breast Augmentation: Three-Year Clinical Data.
Glicksman C, Wolfe A, McGuire P. · · 2024 · cited 8× · PMID 39331509 · DOI 10.1093/asj/sjae134
Ethical Considerations Regarding Financial Incentives in Plastic Surgery-Related Health Research.
Gallo L, Gallo M, Yuan M, Voineskos SH, et al · · 2024 · cited 1× · PMID 39434809 · DOI 10.1177/22925503221151185

Verify or expand the search:

Other Motiva USA LLC trials

Trials by the same sponsor.

NCT06938399 — Motiva Implants® Post-Approval Study · NA · recruiting
NCT05449587 — Long-Term Effectiveness of the Motiva Implants® Round and Round Ergonomix · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03579901 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Motiva USA LLC
Last refreshed: 12 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03579901.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing